Jacobson, Glenn A.
Raidal, Sharanne
Hostrup, Morten
Calzetta, Luigino
Wood-Baker, Richard
Farber, Mark O.
Page, Clive P.
Walters, E. Haydn
Article History
First Online: 13 January 2018
Compliance with Ethical Standards
:
: For the conception and writing of this manuscript, Glenn Jacobson was funded by an ongoing academic appointment at the University of Tasmania.
: Glenn Jacobson and Morten Hostrup have received funding from the World Anti-Doping Agency (WADA), including investigations into the enantioselective detection and performance-enhancing effects of β2-agonists. Sharanne Raidal, Luigino Calzetta, Richard Wood-Baker, Mark O. Farber, and Clive P. Page have not received funding related to this work and have no conflicts of interest to declare. E. Haydn Walters is in receipt of investigator-initiated funding from Boehringer-Ingelheim for a study of airway infection mechanisms in COPD and has received honoraria funding from GlaxoSmithKline for speaking on asthma and COPD therapy to medical practitioners.